Found: 15
Select item for more details and to access through your institution.
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086843
- By:
- Publication type:
- Article
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077753
- By:
- Publication type:
- Article
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03818-y
- By:
- Publication type:
- Article
TGF-β1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate.
- Published in:
- Oncogene, 2001, v. 20, n. 55, p. 7976, doi. 10.1038/sj.onc.1204996
- By:
- Publication type:
- Article
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1952, doi. 10.3390/cancers14081952
- By:
- Publication type:
- Article
Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3201, doi. 10.3390/cancers13133201
- By:
- Publication type:
- Article
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0246244
- By:
- Publication type:
- Article
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49853-z
- By:
- Publication type:
- Article
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.
- Published in:
- Clinical & Experimental Metastasis, 2022, v. 39, n. 6, p. 899, doi. 10.1007/s10585-022-10186-3
- By:
- Publication type:
- Article
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85289-0
- By:
- Publication type:
- Article
Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
- Published in:
- Molecular Carcinogenesis, 2015, v. 54, n. 1, p. 9, doi. 10.1002/mc.22070
- By:
- Publication type:
- Article
Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.
- Published in:
- Molecular Carcinogenesis, 2014, v. 53, n. 3, p. 230, doi. 10.1002/mc.21969
- By:
- Publication type:
- Article
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 209, doi. 10.1007/s11060-018-2950-1
- By:
- Publication type:
- Article
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0214469
- By:
- Publication type:
- Article
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 427, doi. 10.3390/ijms25010427
- By:
- Publication type:
- Article